Have any questions? 706-721-6582 or cts@augusta.edu
Cerevel has begun a study of an investigational drug called CVL-751, also known as Tavapadon, as a possible adjunctive treatment for Parkinsons disease. Tavapadon works by the dopamine system in the brain and is being investigated to see if it can further improve Parkinson Disease symptoms when taking levadopa.